DIRECTNESS:Are there any regulatory hurdles to overcome when using lab-on-a-chip devices in clinical settings?

{
  "winner": 2,
  "reasoning": "NEO is better because it provides a clear and direct response to the question by explicitly affirming that there are potential regulatory hurdles, without including unnecessary or detailed explanations. in contrast, MS, while comprehensive, offers excessive detail that is not needed for a straightforward answer, making it less concise."
}
